期刊文献+

不同剂量促性腺激素释放激素激动剂长方案中黄体生成素水平变化及临床意义 被引量:10

Serum LH levels in different forms and doses of GnRH agonist long protocol and its clinical significance
下载PDF
导出
摘要 不同剂型和剂量的促性腺激素释放激素激动剂(GnRH-a)对垂体的抑制程度不同,因而不同剂型和剂量的GnRH-a长方案中血清黄体生成素(LH)水平也有所不同,从而导致各种方案的临床特征不同。目前研究表明,与短效GnRH-a长方案相比,长效GnRH-a长方案中,促性腺激素(Gn)的使用时间和剂量明显增多,但是二者的临床结局,包括临床妊娠率、活产率、卵巢过度刺激综合征发生率等均无显著性差异。 Different degree of pituitary suppression and various serum LH levels were achieved by using different forms or doses of GnRH agonist (GnRH-a) in long protocol. Therefore the clinical characteristics were also diverse among different long protocols. Compared with short acting GnRH-a, the duration and dosage of exogenous gonadotropin significantly increased in depot GnRH-a long protocol, while the clinical outcomes, such as clinical pregnancy rate, live birth rate and ovarian hyperstimulation syndrome rate, were comparable between the two groups.
作者 黄睿 李婷婷
出处 《生殖医学杂志》 CAS 2013年第10期736-738,共3页 Journal of Reproductive Medicine
关键词 促性腺激素释放激素激动剂 长方案 黄体生成素 垂体抑制 GnRH agonist Long protocol Luteinizing hormone Pituitary suppression
  • 相关文献

参考文献12

  • 1Mohamed KA, Davies WAR, Lashen H. Dynamics of pituitary down regulation and ovarian response to controlled stimulation in in vitro fertilization eycles[J]. Fertil Steril, 2007,87 : 433-435.
  • 2Prato L, Borini A, Trevisi M, et al. Effect of reduced dose o{ triptorelin at the start of ovarian stimulation on the outcome o{ IVF: a randomized study[J] Hum Reprod, 2001,16 : 1409-1414.
  • 3Yim SF, Lok IH, Cheung LP, et al. Dose-fingding study for the use of long-acting gonadotropin-releasing hormone analogues prior to ovarian stimulation for IVF[J]. Hum Reprod, 2001,16:492-494.
  • 4Li Y, Yang DZ, Zhang QX. Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in thelong protocol of controlled ovarian stimulation[J]. J Hum Reprod Sci, 2012,5 : 14-19.
  • 5Janssens RM, Lambalk CB, Vermeiden JP, et al. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study[J]. Hum Reprod,2000,15 : 2333-2340.
  • 6Faber BM, Mayer J, Cox B, et al. Cessation of gonadotropin- releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders[J]. Fertil Steril, 1998,69 ; 826-830.
  • 7Garcia-Velasco JA, Isaza V, Requena A, et al. High doses of gonadotrophins combined with stop versus nonstop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial[J]. Hum Reprod, 2000, 15,2292-2296.
  • 8Sungurtekin U, Jansen RP. Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone- agonist leuprolide acetate[J]. Fertil Steril, 1995,63 : 663-665.
  • 9Maheshwari A, Gibreel A, Siristatidis CS, et al. Gonadotrophin- releasing hormone agonist protocols for pituitary suppression in assisted reproduction (Review) [DB]. Cochrane Database Syst Rev,2011 ,Aug 10, (8) :CD006919.
  • 10Albuquerque LE, Tso LO, Saconato H et al. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles[DB]. Cochrane Database Syst Rev,2013,Jan 31,(1) :CD002808.

同被引文献100

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部